Immuneering (IMRX) Interest Coverage Ratio (2020 - 2026)

Immuneering's Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 0.85 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio rose 98.99% year-over-year to 0.85 in Q1 2026; TTM through Mar 2026 was 3.28, a 96.16% increase from a year earlier, with the FY2025 full-year figure at 0.81, up 25.49% from the prior year.
• Interest Coverage Ratio improved to 0.85 in Q1 2026 per IMRX's latest filing, from 72.75 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 0.51 in Q3 2022 and bottomed at 107.73 in Q4 2022.
• The 5-year median for Interest Coverage Ratio is 2.48 (2024), against an average of 36.05.
• Across the five-year window, Interest Coverage Ratio plunged 2672.66% in 2023 and jumped 98.99% in 2026, its largest moves.
• Year by year, Interest Coverage Ratio stood at 107.73 in 2022, then increased by 21.43% to 84.64 in 2023, then retreated by 19.46% to 101.11 in 2024, then advanced by 28.05% to 72.75 in 2025, then surged by 98.83% to 0.85 in 2026.
• Per Business Quant, the three latest IMRX Interest Coverage Ratio figures stand at 0.85 (Q1 2026), 72.75 (Q4 2025), and 0.52 (Q3 2025).